Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.78M Buy
303,661
+132,225
+77% +$2.56M 0.01% 446
2025
Q4
$2.81M Buy
171,436
+46,651
+37% +$821K 0.01% 558
2025
Q3
$2.35M Hold
124,785
0.01% 566
2025
Q2
$2.52M Buy
124,785
+17,599
+16% +$304K 0.01% 548
2025
Q1
$1.47M Hold
107,186
﹤0.01% 634
2024
Q4
$1.27M Buy
107,186
+16,624
+18% +$262K ﹤0.01% 742
2024
Q3
$1.63M Buy
+90,562
New +$1.65M ﹤0.01% 638

Other funds holding XP

KBC Group's XP Position: Q1 2026 in Review

KBC Group increased its XP (XP) stake by 77% in Q1 2026, buying an estimated $2.56M and bringing the position to 303,661 shares worth $5.78M. The position accounts for 0.01% of the portfolio, ranked #446.

KBC Group first reported a position in XP in Q3 2024 and has held it in 7 quarters since. 356 funds tracked by Wall St. Rank hold XP as of Q1 2026.

  • KBC Group held 303,661 shares of XP worth $5.78M as of Q1 2026.
  • KBC Group bought 132,225 XP shares in Q1 2026, an estimated $2.56M.
  • XP made up 0.01% of KBC Group's portfolio in Q1 2026, its #446 holding.
  • KBC Group first reported a position in XP in Q3 2024 and has held it in 7 quarters since.
  • 356 funds tracked by Wall St. Rank held XP as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.